BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10092013)

  • 21. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
    Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
    J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and application of serotypical synthetic peptides derived from hepatitis C virus NS5A region.
    Dou XG; Zhang L; Li ZW; Feng GH; Chang J; Fildes H; Khudyakov Y
    Chin Med J (Engl); 2007 Jul; 120(13):1159-65. PubMed ID: 17637245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy.
    Chusri P; Kumthip K; Pantip C; Thongsawat S; O'Brien A; Maneekarn N
    Virus Res; 2015 Jan; 196():37-43. PubMed ID: 25445343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial NS4 mosaic antigen of hepatitis C virus.
    Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
    J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
    Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
    J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.
    Devesa M; Khudyakov YE; Capriles F; Blitz L; Fields HA; Liprandi F; Pujol FH
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):639-42. PubMed ID: 9384281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
    Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
    J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of an anti-HCV core peptide ELISA.
    Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
    J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of subtype-specific antibodies to antigenic epitopes in the NS5 region of hepatitis C virus in the circulation of patients with chronic hepatitis C.
    Quiroga JA; Martin J; Pernas M; Pardo M; Herrero M; Castillo I; Bartolome J; Carreño V
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):545-51. PubMed ID: 8556499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
    Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
    J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Kinjo F; Saito A; Nakayoshi T; Yamashiro A
    Microbiol Immunol; 1998; 42(4):299-303. PubMed ID: 9623917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
    Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
    J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees.
    Wang YF; Brotman B; Andrus L; Prince AM
    J Infect Dis; 1996 Apr; 173(4):808-21. PubMed ID: 8603958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
    Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL;
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
    Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
    Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.
    Squadrito G; Leone F; Sartori M; Nalpas B; Berthelot P; Raimondo G; Pol S; Bréchot C
    Gastroenterology; 1997 Aug; 113(2):567-72. PubMed ID: 9247477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.